Ioflupane I 123 Interactions
Showing entire list of all interactions, including brand names and combination drugs.
Go back to interactions summary
Medications known to interact with ioflupane I 123
B
- Banex (guaifenesin / phenylephrine / phenylpropanolamine)
- Banex-LA (guaifenesin / phenylpropanolamine)
- Bel-Phen-Ergot (belladonna / ergotamine / phenobarbital)
- Bel-Tabs (belladonna / ergotamine / phenobarbital)
- Belcomp-PB (belladonna / caffeine / ergotamine / pentobarbital)
- belladonna / caffeine / ergotamine / pentobarbital
- belladonna / ergotamine / phenobarbital
- Bellamine (belladonna / ergotamine / phenobarbital)
- Bellamine S (belladonna / ergotamine / phenobarbital)
- Bellamor (belladonna / ergotamine / phenobarbital)
- Bellaphen-S (belladonna / ergotamine / phenobarbital)
- Bellaspas (belladonna / ergotamine / phenobarbital)
- Bellergal-S (belladonna / ergotamine / phenobarbital)
- benzocaine / phenylephrine / phenylpropanolamine
- benzphetamine
- benztropine
- Bontril PDM (phendimetrazine)
- Bontril Slow Release (phendimetrazine)
- brexpiprazole
- Brisdelle (paroxetine)
- bromocriptine
- brompheniramine / codeine / phenylpropanolamine
- brompheniramine / dextromethorphan / guaifenesin / phenylpropanolamine
- brompheniramine / dextromethorphan / phenylpropanolamine
- brompheniramine / phenylephrine / phenylpropanolamine
- brompheniramine / phenylpropanolamine
- Budeprion (bupropion)
- Budeprion SR (bupropion)
- Budeprion XL (bupropion)
- bupivacaine / ketamine / ketorolac
- Buproban (bupropion)
- bupropion
- bupropion / dextromethorphan
- bupropion / naltrexone
- BuSpar (buspirone)
- buspirone
More about ioflupane I 123
- ioflupane I 123 consumer information
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: diagnostic radiopharmaceuticals
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.